Natus Medical Incorporated
NTUS · NASDAQ
3/31/2022 | 12/31/2021 | 9/30/2021 | 6/30/2021 | |
|---|---|---|---|---|
| Revenue | $119,793 | $128,656 | $113,877 | $115,978 |
| % Growth | -6.9% | 13% | -1.8% | – |
| Cost of Goods Sold | $54,381 | $55,613 | $46,129 | $49,577 |
| Gross Profit | $65,412 | $73,043 | $67,748 | $66,401 |
| % Margin | 54.6% | 56.8% | 59.5% | 57.3% |
| R&D Expenses | $13,224 | $13,750 | $14,267 | $14,249 |
| G&A Expenses | $12,807 | $12,436 | $12,853 | $12,610 |
| SG&A Expenses | $42,358 | $41,731 | $41,113 | $42,098 |
| Sales & Mktg Exp. | $29,551 | $29,295 | $28,260 | $29,488 |
| Other Operating Expenses | $3,598 | $5,632 | $3,681 | $3,919 |
| Operating Expenses | $59,180 | $61,113 | $59,061 | $60,266 |
| Operating Income | $3,641 | $3,848 | $8,545 | $6,014 |
| % Margin | 3% | 3% | 7.5% | 5.2% |
| Other Income/Exp. Net | -$267 | -$217 | -$1,048 | -$651 |
| Pre-Tax Income | $3,374 | $3,631 | $7,497 | $5,363 |
| Tax Expense | $1,471 | $1,886 | $1,924 | $1,899 |
| Net Income | $1,903 | $1,745 | $5,573 | $3,464 |
| % Margin | 1.6% | 1.4% | 4.9% | 3% |
| EPS | 0.056 | 0.052 | 0.17 | 0.1 |
| % Growth | 7.6% | -69.6% | 70% | – |
| EPS Diluted | 0.056 | 0.051 | 0.16 | 0.1 |
| Weighted Avg Shares Out | 34,276 | 33,799 | 33,638 | 33,637 |
| Weighted Avg Shares Out Dil | 34,276 | 34,122 | 33,865 | 33,871 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3 | $0 | $81 | $2 |
| Interest Expense | $267 | $217 | $332 | $556 |
| Depreciation & Amortization | $6,673 | $6,754 | $6,887 | $7,193 |
| EBITDA | $10,314 | $10,602 | $14,716 | $13,112 |
| % Margin | 8.6% | 8.2% | 12.9% | 11.3% |